Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.
暂无分享,去创建一个
S. Solomon | M. Pfeffer | M. Domanski | M. Sabatine | J. Rouleau | E. Braunwald | J. D. de Lemos | J. Šaltytė Benth | A. Maggioni | T. Omland | H. Røsjø
[1] Fred S Apple,et al. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. , 2012, Clinical chemistry.
[2] J. Gea,et al. Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. , 2012, European heart journal.
[3] S. Nygård,et al. Cardiac troponin T levels and exercise stress testing in patients with suspected coronary artery disease: the Akershus Cardiac Examination (ACE) 1 study , 2012, Clinical science.
[4] S. Yusuf,et al. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. , 2011, Clinical chemistry.
[5] T. Edvardsen,et al. Prognostic usefulness of circulating high-sensitivity troponin T in aortic stenosis and relation to echocardiographic indexes of cardiac function and anatomy. , 2011, The American journal of cardiology.
[6] H. White. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? , 2011, Journal of the American College of Cardiology.
[7] Judith S. Hochman,et al. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.
[8] Hani Jneid,et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in c , 2011, Journal of the American College of Cardiology.
[9] Eric Boerwinkle,et al. Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study , 2011, Circulation.
[10] A. Khera,et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.
[11] M. Zhan,et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. , 2010, JAMA.
[12] H. Kauczor,et al. Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque , 2010, Heart.
[13] Mario Plebani,et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. , 2010, European heart journal.
[14] M. Pfeffer,et al. A sensitive cardiac troponin T assay in stable coronary artery disease. , 2009, The New England journal of medicine.
[15] M. Sabatine,et al. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. , 2008, European heart journal.
[16] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[17] J. Alpert,et al. Universal definition of myocardial infarction. , 2007, European heart journal.
[18] D. Atsma,et al. Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation , 2007, Pflügers Archiv - European Journal of Physiology.
[19] M. Pfeffer,et al. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. , 2007, Journal of the American College of Cardiology.
[20] M. Pfeffer,et al. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. , 2004, The New England journal of medicine.
[21] J. V. Van Eyk,et al. Developing the next generation of cardiac markers: disease-induced modifications of troponin I. , 2004, Progress in cardiovascular diseases.
[22] M. Pencina,et al. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation , 2004, Statistics in medicine.
[23] Carl J Pepine,et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients , 2002, Circulation.
[24] J. Canty,et al. Preload Induces Troponin I Degradation Independently of Myocardial Ischemia , 2001, Circulation.
[25] D. Atar,et al. Extensive Troponin I and T Modification Detected in Serum From Patients With Acute Myocardial Infarction , 2000, Circulation.
[26] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[27] J. Alpert,et al. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction , 2008 .
[28] D. Petrovic,et al. Cardiac troponins and left ventricular hypertrophy in hemodialysis patients. , 2008, Clinical laboratory.